2024-12-20 19:32:54

Novo Nordisk spokesperson: Regulatory filing for Cagrisema is expected by the end of 2025. We are encouraged by the properties of Cagrisema, which appears safe, well tolerated, and broadly similar to other GLP-1s.
Email Subscription
Newsletters and emails are now available! Delivered on time, every weekday, to keep you up to date with North American business news.
ASIA TECH WIRE

Grasp technology trends

Download